Pharmeco is a vertically integrated holding company operating across the pharmaceutical market, focusing on research, development, production, and distribution of drugs and medical products. Established to support Russia’s import substitution strategy, Pharmeco aims to ensure the availability of high-quality, domestically-produced medications.

Founded to enhance Russia’s pharmaceutical landscape, Pharmeco encompasses a broad range of services and capabilities, including proprietary drug development, GMP-compliant manufacturing, and nationwide distribution. Its manufacturing plants produce both local and internationally licensed medicines, while its distribution arm serves essential healthcare programmes, such as those for oncology, diabetes, and HIV.

Key Products and Services

• Pharmaceutical research and development (R&D)
• GMP-certified drug manufacturing
• Medical equipment production
• Nationwide distribution through IRWIN
• Support for state healthcare programmes

With its comprehensive approach to pharmaceuticals, Pharmeco plays a crucial role in improving public health and advancing Russia’s healthcare system.